汇添富中证全指医疗器械ETF发起式联接C(017633)财务指标
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 本期已实现收益 |
-72,470.58 |
-459,405.56 |
-164,431.68 |
-352,510.17 |
| 本期利润 |
-169,373.42 |
-973,788.12 |
-1,672,027.13 |
-910,453.13 |
| 加权平均基金份额本期利润 |
-0.01 |
-0.07 |
-0.14 |
-0.18 |
| 本期加权平均净值利润率(%) |
-1.75 |
-9.63 |
-18.10 |
-19.57 |
| 本期基金份额净值增长率(%) |
-1.10 |
-13.85 |
-15.69 |
-13.41 |
| 期末可供分配利润 |
-3,354,316.45 |
-3,438,111.76 |
-4,352,450.19 |
-995,301.62 |
| 期末可供分配基金份额利润 |
-0.26 |
-0.25 |
-0.27 |
-0.13 |
| 期末基金资产净值 |
9,426,887.30 |
10,085,141.52 |
11,760,158.41 |
6,418,469.89 |
| 期末基金份额净值 |
0.74 |
0.75 |
0.73 |
0.87 |
| 基金份额累计净值增长率(%) |
-26.24 |
-25.42 |
-27.01 |
-13.43 |
微信公众号
证券之星APP
基本资料
